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Background and aims: Major liver resection incurs a risk of postoperative liver dysfunction and infection
and there is a lack of objective evidence relating residual liver volume to these complications.
Patients and methods: Liver volumetry was performed on computer models derived from computed
tomography (CT) angioportograms of 104 patients with normal synthetic liver function scheduled for liver
resection. Relative residual liver volume (%RLV) was calculated as the relation of residual to total functional
liver volume and related to postoperative hepatic dysfunction and infection. Receiver operator
characteristic curve analysis was undertaken to determine the critical %RLV predicting severe hepatic
dysfunction and infection. Univariate analysis and multivariate logistic regression analysis were performed
to delineate perioperative predictors of severe hepatic dysfunction and infection.
Results: The incidence of severe hepatic dysfunction and infection following liver resection increased
significantly with smaller %RLV. A critical %RLV of 26.6% was identified as associated with severe hepatic
dysfunction (p,0.0001). Additionally, body mass index (BMI), operating time, and intraoperative blood
loss were significant prognostic indicators for severe hepatic dysfunction. It was not possible to predict the
individual risk of postoperative infection precisely by %RLV. However, in patients undergoing major liver
resection, infection was significantly more common in those who developed postoperative severe hepatic
dysfunction compared with those who did not (p = 0.030).
Conclusions: The likelihood of severe hepatic dysfunction following liver resection can be predicted by a
small %RLV and a high BMI whereas postoperative infection is more related to liver dysfunction than
precise residual liver volume. Understanding the relationship between liver volume and synthetic and
immune function is the key to improving the safety of major liver resection.
L
iver resection of primary and secondary malignancies has
becoming increasingly important in recent decades.1–5
Based on promising survival results and a perioperative
mortality rate of ,5%, the frontiers of liver surgery are
extending continuously towards more major liver resections
leaving smaller fractions of residual liver.6–8 At the same time,
a significant increase in postoperative morbidity due to
hepatic dysfunction and infectious complications following
extended liver resection has been reported, even by very
specialised centres.7 9 10 The paradigm that at least a third of
healthy liver tissue should be left to avoid hepatic failure
following resection was developed long ago but few data exist
to support this arbitrary value in patients with otherwise
healthy livers. The expansion of major liver surgery as a
treatment option for various liver tumours has presented new
challenges to surgeons and physicians in terms of the
assessment and management of postoperative complications,
particularly those involving hepatic insufficiency and sus-
ceptibility to infection.
The liver contains the largest reserve of fixed tissue
macrophages in the body (Kupffer cells) and regulates the
synthesis of hepatic proteins responsible for recognition and
opsonisation of pathogens as part of the innate immune
system.11 It was shown previously that innate immunity is
significantly impaired in acute and chronic liver failure and
after liver surgery, suggesting a link between changes in
innate immune response and postoperative infection follow-
ing major liver resection.12–17 The contribution of the liver to
maintain various pathways of innate immunity and its
relation to liver volume and global hepatic function after
liver resection have hitherto not been explored.
Measurement of total and partial liver volumes based on
computed tomography (CT) and magnetic resonance image
analysis has become popular to estimate actual graft size
before resection in living related liver transplantation.18–20
Some studies have addressed the predictive value of residual
liver volume regarding liver function and complications after
major liver resection.21 22 However, most of this work has
been done in patients with chronic liver disease.23–26 We have
shown previously that preoperative estimation of residual
liver volume by CT angioportography (CTAP) image based
volumetry provides accurate measures of the actual amount
of hepatic parenchyma left after liver resection.27 The aim of
the present study was to use three dimensional hepatic
volumetry and virtual resection to define the critical residual
liver volume associated with the development of hepatic
dysfunction in patients with a healthy liver undergoing liver
resection. Furthermore, we wished to establish whether there
is a relationship between residual liver volume, liver function,
and the incidence of postoperative infection.
PATIENTS AND METHODS
Patients and surgical technique
Volumetric analysis of the liver was performed in patients
who were admitted to the Hepatobiliary Unit, Royal
Infirmary Edinburgh, for a liver resection and had CTAP
done as part of their preoperative assessment. No patient had
Abbreviations: CT, computed tomography; CTAP, CT angioportography;
BMI, body mass index; ROC, receiver operator characteristic; TLV, total
liver volume; TuV, tumour volume; TFLV, total functional liver volume; RLV,
residual liver volume; %RLV, relative residual liver volume
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any background of chronic liver disease and all gave written
informed consent. Selection of patients for surgery and the
technique of hepatic resection have been described pre-
viously.28 Briefly, surgery for liver tumours was based on
segment oriented anatomical resection.29 With the anaesthe-
tist maintaining a low central venous pressure (3–5 cmH2O),
liver transection was performed using a Cavitron ultrasonic
surgical aspirator (CUSA System 200 Macrodissector;
Cavitron Surgical Systems, Stamford, Connecticut, USA)
without the need for extrahepatic vascular occlusion. The
resected liver surface was sealed haemostatically using argon
beam coagulation (Force GSU System; Valleylab, Boulder,
Colorado, USA). The extent of liver resection was defined
according to the number of liver segments removed and
grouped into extended (five or more segments), standard
(three or four segments), and minor (one or two segments or
wedge resection) resections.
Liver volumetry and calculation of relative residual
liver volume
Liver volumetry was performed on sets of axial images which
were obtained preoperatively during CTAP. The majority of
images were taken from a spiral CT GE Hispeed Advantage
scanner (General Electric Medical Systems, Milwaukee,
Wisconsin, USA) using an image slice thickness of 7 mm.
In the latest phase of the study, 1 mm image slices were
obtained from a multi-slice CT Toshiba Aquilion 16 scanner
(Toshiba Medical Systems, California, USA). Medical image
analysis software GE Advantage Windows and Analyze 5.0
(Analyze Direct, Inc; Biomedical Imaging Resource, Mayo
Foundation, Rochester, USA) were used for volumetry. Every
slice from the GE scanner and every fifth slice from the
Toshiba scanner were analysed in the following way. The
outline of the region of interest was traced manually in each
image section, excluding the gall bladder, retro hepatic vena
cava, and main branches of the intrahepatic vascular
structures. An automated process stacked all slices together
to build a virtual model of the liver. Volumetric values were
obtained by the inherent software volume rendering algo-
rithm. Total liver volume (TLV) and tumour volume (TuV)
were measured and total functional liver volume (TFLV) was
calculated by subtracting tumour volume from total liver
volume (TFLV = TLV 2 TuV) (fig 1A). The model of the
whole liver was then subjected to virtual hepatic resection
according to the operative strategy for each individual patient
and the volume of segments to be resected, and residual liver
volume (RLV) was measured (fig 1B, C). Relative residual
liver volume (%RLV) was expressed as a percentage of TFLV.
When the type of resection actually performed was different
from that estimated preoperatively, volumetric analysis was
repeated.
Definition of postoperative complications, hepatic
dysfunction, inflammation and infection, and body
mass index
Postoperative complications included surgical complications
(bleeding from the surgical site and bile leak), hepatic
dysfunction, cardiovascular, respiratory, and renal system
dysfunction, and infection. These complications were
assessed on a daily basis starting from the day of surgery
until discharge. Readmission due to problems related to the
previous operation was also included. The definition of
postoperative hepatic dysfunction was based on serum
concentrations of total bilirubin and lactate, prothrombin
time, and signs of encephalopathy, categorised into four
grades (none/mild/moderate/severe) (table 1).7 30 31 No, 1, or 2
points were given for each parameter according to the actual
results, and summation of all provided the actual score.
Parameters were taken into account only when present for
two consecutive observations within a 48 hour period. The
highest score during the postoperative course determined the
severity of hepatic dysfunction (table 1).
The definitions of cardiovascular, respiratory, and renal
system dysfunction were taken from two consecutive reports
Figure 1 (A–C) Three dimensional liver volumetry of an extended right hepatectomy with caudate excision. (A) Total liver volume (TLV =1133 ml; red
colour); tumour volume (TuV=34 ml; green colour); and total functional liver volume (TFLV=1099 ml). (B) Residual liver volume (RLV =293 ml yellow
colour) from three dimensional liver model after virtual resection; relative residual liver volume (%RLV=26.7%). (C) Intraoperative view of the residual
liver following resection.
Table 1 Definition of postoperative hepatic dysfunction based on results from blood tests
and clinical observation
Total serum bilirubin (mmol/l) (20 21–60 .60
Prothrombin time (seconds above normal) ,4 4–6 .6
Serum lactate (mmol/l) (1.5 1.6–3.5 .3.5
Encephalopathy grade No 1 and 2 3 and 4
0 1 2
Severity of hepatic dysfunction None (0), mild (1–2), moderate (3–4), severe (.4)
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by the American College of Chest Physicians/Society of
Critical Care Medicine Consensus Conferences.32 33 Clinically
significant infections only were taken into account and
defined as coincidence of positive microbial culture together
with either local or general symptoms of inflammation.32–34
Perioperative death was defined as death within 30 days or
during the hospital stay following surgery if this was greater.
Severe hepatic dysfunction and infection, but not moderate
or mild hepatic dysfunction, had a significant adverse
influence on the duration of hospital stay and were chosen
as primary end points.
Statistical analysis
Statistical analysis was performed using SPSS 11.0 statistical
analysis software (SPSS Inc., Chicago, Illinois, USA). One
way between group ANOVA analysis of variance was
performed in order to assess differences in %RLV between
different types and extent of liver resection and between
patients with and without different severities of hepatic
dysfunction. The independent sample t test was used to
assess differences in %RLV between patients with and
without infection. Receiver operator characteristic (ROC)
curve analysis was undertaken to identify the value of %RLV
in predicting severe hepatic dysfunction and infection with a
sensitivity of at least 90% and a specificity of not less than
85%. The positive predictive value of the critical %RLV for
severe hepatic dysfunction was calculated for the study
group. Univariate analysis of preoperative and intraoperative
variables was performed by Pearson x2 and Fisher’s exact
test, respectively, for categorical variables and independent
sample t test for continuous variables. Significant variables in
univariate analysis were entered simultaneously (forced
entry method) into multivariate logistic regression to
evaluate their independent predictive value for severe hepatic
dysfunction and infection.
RESULTS
Patient demography, diagnosis, and the extent of
liver resection
Volumetry of the liver was performed in 104 patients (59
males and 45 females; mean age 61 (SD 12) years) who
consecutively underwent liver resection. The diagnosis was
colorectal cancer liver metastasis in 92 (88.5%), other
secondary malignancies in six (5.8%), adenoma in two
(1.9%), and hepatocellular carcinoma, cholangiocarcinoma,
haemangiosarcoma, and focal nodular hyperplasia in one
(1.0%) patient each. In total, 27 (26.0%) extended resections,
57 (54.8%) standard resections, and 20 (19.2%) minor
resections were performed (fig 2). Mean %RLV was 30.8
(SD 12.1)% after extended liver resection, 40.2 (14.5)% after
standard resection, and 82.9 (9.2)% after minor resection
(one way between groups ANOVA: p=0.007 between
standard and extended resection; p,0.0001 between minor
and standard or extended resection). In 36 of 104 (34.6%)
patients, less than 33% RLV was left after resection.
Postoperative complications and their relation to
residual liver volume
In 54 of 104 (51.9%) patients, one or more complications
became evident following liver resection. Thirty three (31.7%)
patients developed postoperative infection as the most
common cause of complications. Mild, moderate, and severe
hepatic dysfunction were evident in 42 (40.4%), 22 (21.2%),
and 13 (12.5%) patients. Pleural effusions were found in 11
(10.6%), a bile duct leak in six (5.8%), renal dysfunction in
four (3.8%), pulmonary embolism in three (2.9%), temporary
atrial fibrillation in three (2.9%), bleeding from the surgical
site requiring reoperation in two (1.9%), and portal vein
 
 	









 


 










   
 


 !

 "
#
 
$%
 "

 "
$%

 "




 













&	
'
Figure 2 Mean (SD) relative residual liver volume (%RLV) of different
types of extended (Ext R Hep, extended right hepatectomy; Ext L Hep,
extended left hepatectomy), standard (R Hep, right hepatectomy; Centr
Trisegm, central trisegmentectomy; L Hep, left hepatectomy), and minor
(R Post Sect, right posterior sectionectomy; L Lat Sect, left lateral
sectionectomy; Segment, segmentectomy) liver resection. Reference line
indicates 33% RLV.
Table 2 Hepatic dysfunction and infection following
minor, standard, and extended liver resection
Extent of liver resection
Minor
(n = 20)
Standard
(n = 57)
Extended
(n = 27)
Postoperative hepatic dysfunction****
No 17 (85.0) 9 (15.8) 1 (3.7)
Mild 3 (15.0) 28 (49.1) 11 (40.7)
Moderate 0 15 (26.3) 7 (25.9)
Severe 0 5 (8.8) 8 (29.6)
Infection*** 3 (15.0) 14 (24.6) 16 (59.3)
***p=0.001, ****p,0.0001 by Pearson x2.
Values in parentheses are percentages of patients in each category by
extent of liver resection.
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Figure 3 Mean (SD) relative residual liver volume (%RLV) in patients
with no, mild, moderate, and severe hepatic dysfunction following liver
resection (one way between group ANOVA; **p=0.005,
***p,0.0001). Reference line indicates 33% RLV.
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thrombosis and upper gastrointestinal tract bleeding in one
(1%) patient each. Two of 104 (1.9%) patients died; both
developed liver failure (in one associated with sepsis)
following extended liver resection. The incidence of post-
operative hepatic dysfunction in general and severe hepatic
dysfunction in particular increased with the extent of liver
resection (table 2). Five of 57 (8.8%) patients after standard
liver resection and eight of 27 (29.6%) patients after extended
liver resection, but none after minor resection, developed
severe hepatic dysfunction.
Mean %RLV was significantly smaller in patients who
developed mild hepatic dysfunction compared with those
without hepatic dysfunction (42.9 (15.4)% and 69.9 (22.6)%;
p,0.0001) (fig 3). Patients who developed severe hepatic
dysfunction had a significantly smaller mean %RLV com-
pared with those with mild hepatic dysfunction (24.5 (6.0)%
and 42.9 (15.4)%; p=0.005) (fig 3). The number of patients
who developed postoperative infection increased from minor
to standard liver resection and was highest after extended
liver resection (table 2). Mean %RLV was significantly
smaller in patients with postoperative infection compared
with those without infection (38.8 (18.5)% and 49.3 (23.6)%;
independent sample t test, p=0.016).
Receiver operator characteristic (ROC) curve analysis
of %RLV to predict severe hepatic dysfunction and
infection following liver resection
ROC curve analysis revealed that a %RLV value of 26.6%
identified patients at significant risk for severe hepatic
dysfunction following liver resection (fig 4A). Using this
value it was possible to predict severe hepatic dysfunction in
patients undergoing liver resection with 90.9% sensitivity and
87.1% specificity. The positive predictive value for the study
group was 50.2%, the likelihood ratio for a positive test result
(,26.6% RLV) associated with severe hepatic dysfunction
was 7.0, and for a negative test result (>26.6% RLV) 0.1. Ten
of 22 (45.5%) patients with a %RLV value of ,26.6%
developed severe hepatic dysfunction compared with one of
82 (1.2%) with a larger %RLV (p,0.0001) (fig 4B). However,
12 of 22 (54.5%) patients with a %RLV value below the
critical %RLV did not develop severe hepatic dysfunction. It
was not possible to identify a precise %RLV value for
predicting postoperative infection by ROC curve analysis
(fig 5A). Applying the critical %RLV of 26.6% to predict
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Figure 4 (A) Receiver operator characteristic (ROC) curve analysis of
relative residual liver volume (%RLV) to predict postoperative severe
hepatic dysfunction. A critical %RLV value of 26.6% was identified (area
under the curve = 0.918 (95% confidence interval 0.854–0.983);
p,0.0001). (B) Incidence of severe hepatic dysfunction following liver
resection according to %RLV. Reference line indicates the critical %RLV of
26.6% associated with a significant risk of postoperative severe hepatic
dysfunction (Fisher’s exact test; p,0.0001).
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Figure 5 (A) Receiver operator characteristic (ROC) curve analysis of
relative residual liver volume (%RLV) to predict postoperative infection.
No critical %RLV was identified in predicting infection with precision
(area under the curve =0.641 (95% confidence interval 0.528–0.755);
p = 0.021). (B) Incidence of infection following liver resection according
to %RLV (Fisher’s exact test, p = 0.069). Reference line indicates 26.6%
RLV.
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postoperative infection, sensitivity was 33.3% and specificity
84.5%. The likelihood ratio for a positive test result (,26.6%
RLV) associated with postoperative infection was 2.1 and for
a negative test result (>26.6% RLV) 0.8. Eleven of 22 (50.0%)
patients with a %RLV below 26.6% developed postoperative
infection compared with 22 of 82 (26.8%) with a larger %RLV
(p=0.069) (fig 5B).
Ability of %RLV in association with other preoperative
and intraoperative parameters to predict
postoperative severe hepatic dysfunction and
infection
Univariate analysis revealed that small %RLV (p,0.0001),
high body mass index (BMI) (p,0.0001), extended liver
resection (p=0.007), prolonged operating time (p=0.001),
increased blood loss during surgery (p=0.007), and peri-
operative blood transfusion (p=0.003) were significant
predictors of severe hepatic dysfunction following liver
resection (tables 3, 4). Extended liver resection (p=0.001),
small %RLV (p=0.016), and prolonged operating time
(p=0.009) showed significant value in predicting post-
operative infection (tables 3, 4). %RLV together with BMI,
operating time, intraoperative blood loss, and perioperative
blood transfusion were entered into a logistic regression
model to identify variables with independent predictive value
for severe hepatic dysfunction and infection. A small %RLV
and high BMI were found to be significant independent
predictors of severe hepatic dysfunction (table 5). However,
prolonged operating time and large intraoperative blood loss
increased the accuracy of this regression model. By applying
BMI, operating time, and intraoperative blood loss to the risk
assessment of patients with a small %RLV, it became possible
to distinguish between patients who developed severe hepatic
dysfunction and those who did not (fig 6). A small %RLV and
prolonged operating time were the only two significant
independent predictors of postoperative infection (table 5).
Incidence of infection in patients with and without
postoperative severe hepatic dysfunction
In order to analyse the relation between impaired liver
function and susceptibility to infection, we compared the
incidence of postoperative infection between patients who
developed postoperative severe hepatic dysfunction and those
who did not. The analysis was limited to patients with less
than 26.6% RLV because severe hepatic dysfunction was
almost exclusively seen in this group. Eight of 11 (72.7%)
patients with postoperative severe hepatic dysfunction
developed infection whereas this was the case in two of 11
(18.2%) without severe hepatic dysfunction (p=0.030)
(table 6).
DISCUSSION
Liver resection is still accompanied by a certain risk of
postoperative complications and the overall incidence of
complications is significantly increasing towards extended
liver resections.7 23 Hepatic dysfunction and infection are the
two most common conditions necessitating prolonged treat-
ment and hospital stay following liver resection.7 30 35 36 One
key to improve the safety of liver resection is to understand
the relationship between liver volume and function. There is
a lack of evidence to support the assumption that at least one
third of a healthy liver should be left to avoid significant
hepatic dysfunction, and adequacy of RLV in the past has
been based largely on guesswork or crude measures rather
than precise measurements. Similarly, the relation between
Table 3 Preoperative and intraoperative categorical predictors for severe hepatic
dysfunction and infection
Severe hepatic
dysfunction p Value Infection p Value
Sex
Male 59 9 (15.3) 0.109* 22 (37.3) 0.204*
Female 45 2 (4.4) 11 (24.4)
Extent of resection
Minor 20 0 0.007** 3 (15.0) 0.001**
Standard 57 4 (7.0) 14 (24.6)
Extended 27 7 (25.9) 16 (59.3)
Hepatic inflow occlusion
No 76 9 (11.8) 1.000* 25 (32.9) 1.000*
Yes 16 2 (12.5) 5 (31.3)
Blood transfusion
No 69 3 (4.3) 0.003* 17 (24.6) 0.080*
Yes 25 7 (28.0) 11 (44.0)
*Fisher’s exact test or **Pearson x2.
Table 4 Mean (SD) values of preoperative and intraoperative predictors for severe hepatic dysfunction and infection
(independent sample t test)
Severe hepatic dysfunction Infection
Yes No p Value Yes No p Value
Age 59.5 (14.7) 61.1 (11.9) 0.681 63.5 (8.9) 59.8 (13.3) 0.097
BMI 29.9 (6.1) 24.6 (4.2) ,0.0001 26.2 (4.6) 24.6 (4.7) 0.121
%RLV 23.1 (4.9) 48.7 (22.3) ,0.0001 38.8 (18.5) 49.3 (23.6) 0.016
Operating time (min) 264.6 (31.3) 211.3 (53.1) 0.002 237.1 (52.2) 207.5 (52.1) 0.009
Blood loss (ml) 2090.7 (1242.2) 1059.5 (924.2) 0.007 1419.7 (1029.7) 1025.9 (949.4) 0.085
BMI, body mass index; %RLV, relative residual liver volume.
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small residual liver, liver dysfunction, and postoperative
infection has not been defined.
This study aimed to identify the critical residual liver
volume able to predict postoperative severe hepatic dysfunc-
tion and to investigate the relationship between small
residual liver and postoperative infection. We studied only
patients without chronic liver disease to enable an estimate of
the maximum capacity of the healthy liver before hepatic
dysfunction or infection supervene. An accurate and vali-
dated technique of virtual resection in three dimensional liver
models was used to calculate the precise volumes associated
with liver resection.27 By subtracting tumour volume from
total liver volume, the percentage of RLV in relation to
functional liver volume rather than total volume was
calculated, thus taking into account the extent of hepatic
replacement by large tumours that clearly would not
contribute to the functional liver volume. Using this
approach, we have demonstrated that volumetric image
analysis provides more precise information about the amount
of liver tissue left after resection compared with other
estimates based on either the type of resection or number
of liver segments removed.
There is no consensus on how to define hepatic dysfunc-
tion after liver resection and several studies have used
different estimates of liver function to describe hepatic
functional impairment.21–23 37 Some of the variables used to
define postoperative hepatic dysfunction, namely alanine
aminotransferase, gamma-glutamyl transferase, and alkaline
phosphatase, are influenced by the surgical insult to and
regeneration of the remaining liver rather than reflecting
hepatic function. For the purpose of this study, a novel
scoring system of hepatic dysfunction following liver resec-
tion was introduced which was derived from routine blood
tests and clinical observations. We found a good correlation
between liver dysfunction scores and %RLV, and a critical
minimum %RLV of 26.6% was identified below which serious
hepatic dysfunction is likely to occur. According to our
findings, this is the first study using ROC curve analysis to
define a precise %RLV that is able to predict the individual
likelihood of postoperative severe hepatic dysfunction. Two
other studies reported a %RLV of less than 25% as being
associated with significant liver dysfunction in patients with
normal liver.21 22 However, the cut off for %RLV in these
studies was not derived from precise analysis but rather it
was set arbitrarily to compare results of liver function and
overall complications between different extents of resection.
We believe that calculating %RLV before major liver
resection provides useful information for planning hepatic
surgery and in advising individual patients of the potential
risks of their surgery. However, it should not be a barrier to
undertake major liver resection when the chance for cure and
the patient’s good condition outweighs the risk. Only half of
patients who underwent liver resection leaving less than the
critical %RLV developed postoperative severe hepatic dys-
function. However, in all of these patients additional
predictive factors, such as high BMI, long operating time,
and significant intraoperative blood loss, were evident. BMI
was found as a reliable surrogate marker of hepatic steatosis
and steatosis is known as a potential risk factor for major
liver resection.38 39 We found a good correlation between the
number of liver specimens showing moderate to severe
steatosis and BMI, supporting the assumption that steatosis
is an important factor for the development of hepatic
dysfunction in patients who underwent liver resection
leaving only a small %RLV. This observation is of particular
Table 5 Multivariate logistic regression analysis of variables to predict severe hepatic
dysfunction and infection following liver resection
B SE Wald p Value Exp(B) 95% CI for Exp(B)
Severe hepatic dysfunction
%RLV 20.358 0.133 7.271 0.007 0.699 0.539–0.907
BMI 0.280 0.139 4.056 0.044 1.323 1.008–1.738
Blood loss 0.001 0.001 2.194 0.139 1.001 1.000–1.002
Operating time 20.008 0.013 0.386 0.534 0.992 0.967–1.018
Infection
%RLV 20.029 0.010 9.282 0.002 0.971 0.953–0.990
Operating time 0.003 0.002 2.075 0.150 1.003 0.999–1.006
BMI, body mass index; %RLV, relative residual liver volume.
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Figure 6 Incidence of severe hepatic dysfunction following liver
resection in relation to relative residual liver volume (%RLV) and the
presence of the additional risk factors body mass index .30 (BMI),
operating time.240 minutes and/or blood loss.2000 ml (Intraop), or
both (BMI+Intraop). Reference line indicates the critical %RLV of 26.6%.
Table 6 Relation of severe hepatic dysfunction and
infection following major liver resection in patients with a
small (,26.6%) residual liver volume
Severe hepatic dysfunction (%)
No Yes
11 11
Infection No 9 (81.8) 3 (27.3)
Yes 2 (18.2) 8 (72.7)
Fisher’s exact test; p = 0.030.
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interest as BMI can easily be calculated before surgery and
included in the preoperative risk assessment.
Infections are seen frequently after liver resection and in
the present study caused a significant proportion of post-
operative complications. Several studies suggest an important
role for the liver in postoperative innate immune response40 41
but no single study has investigated the relationship between
RLV and the incidence of postoperative infection. Significant
loss of hepatic phagocytes (Kupffer cells) together with
decreased synthesis of hepatic proteins involved in antigen
recognition, opsonisation, and phagocytosis are considered
likely to be responsible for the impaired innate immune
function following major liver resection and consequently
render the patient more susceptible to infection.13 17 42–44 We
found a significant relation between the extent of liver
resection, %RLV, and the incidence of postoperative infection.
However, a precise %RLV to predict infection with high
sensitivity and specificity could not be defined. Postoperative
infections are a heterogeneous group of diagnoses.45 Some
may be dependent on the condition of the patient, the extent
of liver resection performed, and liver function, but others
will be determined by many other factors. Thus lack of a
definitive cut off value for %RLV in predicting infection
following liver resection might be explained by the study
being under powered to account for such heterogeneity
rather than there being no true relationship. Analysis of a
subgroup of patients with small residual liver volume showed
a significant relation between severe hepatic dysfunction and
infection, supporting the proposed relationship between liver
function, innate immunity, and susceptibility to infection.
Studies assessing the reticuloendothelial cell clearance capa-
city of healthy and diseased liver after major liver resection
would be useful in further evaluating the relation between
residual liver volume, liver function, and innate immunity.
Estimating %RLV from three dimensional hepatic volume-
try and virtual resection in patients undergoing liver resection
provides important information in assessing the individual
risk for postoperative severe hepatic dysfunction. A critical
%RLV of 26.6% was identified below which the risk of
developing severe hepatic dysfunction increased significantly.
Additionally, obesity renders patients even more likely to
develop severe hepatic dysfunction following resection.
Although we found an association between small %RLV
and postoperative infection, it was not possible to define this
risk in terms of a critical %RLV with precision. Studies
assessing the various aspects of liver function, including its
contribution to innate immunity, and relating these results to
actual preoperative and estimated residual liver volume
would be of value in understanding the relationship between
liver volume and function in further detail. This would also
help in developing novel strategies to reduce the incidence of
complications related to hepatic dysfunction following major
liver resection.
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Gut Tutorial: chronic diarrhoea
Educational objectives
This web based case is designed to take around 30 minutes to complete. You can leave it at
any time and return to complete it at another time if you need to. It is aimed at consultant
gastroenterologists and specialist registrars in gastroenterology.
After working through this tutorial you should be:
N familiar with the likely causes of painful chronic diarrhoea
N aware of symptom patterns and diagnostic tests for
– coeliac disease
– Lactose intolerance
– Giardiasis
– Irritable bowel syndrome
– Crohn’s disease
– Bile salt malabsorption
– post cholecystectomy diarrhoea
– Microscopic colitis
– familiar with management of the above
Clinical details
This 32 year old female school teacher was referred because of longstanding diarrhoea and
abdominal pain with recent exacerbation. She had a normal bowel habit, opening her
bowels once a day until the age of 26 when she suffered acute bacterial gastroenteritis while
on a backpacking holiday in one of the US National Parks. Her main complaint was of colicky
lower abdominal pain, which often preceded the urge to defecate.
This pain was usually but not always relieved by defecation. She opened her bowels up to
12 times per day, on awakening and soon after each main meal of the day with occasional
bowel movements at other times. She was not often awakened by the need to defecate at
night although she did suffer from disturbed sleep. The stool consistency was variable, mainly
loose but sometimes normal. She would occasionally pass mucous when the stool was hard.
When she had frequent bowel movements there was often anal soreness and streaks of bright
red blood on the toilet paper. She also complained of abdominal distension and bloating,
worse towards the end of the day. Her appetite was poor and she had lost about 6 lb in
weight over the past few months, during which time her symptoms had been worse. She
completed a symptom diary which tells the story eloquently.
To take part in this Gut Tutorial, go to http://cpd.bmjjournals.com/cgi/hierachy/
cpd_node;89.
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